You just read:

Results From Combination of APR-246 with Immuno-Oncology Agents Presented at the 2019 American Association for Cancer Research (AACR) Annual Meeting in Atlanta

News provided by

Aprea Therapeutics AB

Apr 03, 2019, 08:00 ET